Should You Be Impressed By IQVIA Holdings Inc.'s (NYSE:IQV) ROE?
IQVIA Q2 2024 Earnings Preview
How Is The Market Feeling About IQVIA Hldgs?
IQVIA Hldgs's (NYSE:IQV) short percent of float has fallen 5.39% since its last report. The company recently reported that it has 3.08 million shares sold short, which is 1.93% of all regular shares
Notable Earnings Before Monday's Open
Investors Still Waiting For A Pull Back In IQVIA Holdings Inc. (NYSE:IQV)
With a price-to-earnings (or "P/E") ratio of 30.2x IQVIA Holdings Inc. (NYSE:IQV) may be sending very bearish signals at the moment, given that almost half of all companies in the United States have
IQVIA (IQV) to Report Q2 Earnings: What's in the Offing?
IQVIA Holdings, Inc. (IQV Quick QuoteIQV - Free Report) is scheduled to release its second-quarter 2024 results on Jul 22, before market open.
Is Now The Time To Look At Buying IQVIA Holdings Inc. (NYSE:IQV)?
Express News | IQVIA Holdings Inc : Leerink Partners Cuts Target Price to $267 From $278
S&P 500 Futures Flat In Premarket Trading; Wells Fargo, Hologic Lag
This article was automatically generated by Barrons.com using technology from Automated Insights. With U.S. stock markets set to open in two hours, Meritage Homes Corp. (MTH) was up 5.8% in pre-
Will IQVIA Holdings (IQV) Bounce Back?
IQVIA Named a Leader in Medical Affairs and Regulatory Operations by Everest Group
IQVIA (NYSE:IQV) today announces that a leading, independent research firm, Everest Group, has recognized IQVIA as a Leader in its Life Sciences Regulatory and Medical Affairs Operations PEAK Matrix
Express News | Baird Maintains Neutral on IQVIA Hldgs, Lowers Price Target to $235
Baird Maintains IQVIA Holdings(IQV.US) With Hold Rating, Cuts Target Price to $235
Baird analyst Eric Coldwell maintains $IQVIA Holdings(IQV.US)$ with a hold rating, and adjusts the target price from $241 to $235.According to TipRanks data, the analyst has a success rate of 53.1%
Drug Middlemen Pay Higher Prices to Their Own Pharmacies, Says FTC
(July 9): Drug middlemen paid their own mail-order pharmacies as much as 200 times more than the price at rival pharmacies for commonly prescribed cancer drugs, allowing them to bring in at least US$1 billion (RM4.71 billion) in excess revenue and potentially raising the costs to patients, the US Federal Trade Commission (FTC) found in an interim study.
Express News | IQVIA Holdings Inc : Baird Cuts Target Price to $235 From $241
Express News | Evercore ISI Group Maintains Outperform on IQVIA Hldgs, Lowers Price Target to $230
Evercore ISI Adjusts Price Target on IQVIA Holdings to $230 From $250, Maintains Outperform Rating
IQVIA Holdings (IQV) has an average outperform rating and a price target range of $241 to $295, according to analysts polled by Capital IQ.
IQVIA to Announce Second-Quarter 2024 Results on July 22, 2024
IQVIA Holdings Inc. ("IQVIA") (NYSE:IQV) will announce its second-quarter 2024 financial results before the market opens on Monday, July 22, 2024. The IQVIA management team will also host a conference call and webcast
IQVIA Holdings Inc.'s (NYSE:IQV) Intrinsic Value Is Potentially 64% Above Its Share Price
10 Health Care Stocks With Whale Alerts In Today's Session
This whale alert can help traders discover the next big trading opportunities.Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scan